Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials - TAP report 2
2001
Abstract
To report 24-month vision and fluorescein angiographic outcomes from trials evaluating photodynamic therapy with verteporfin (Visudyne; CIBA Vision Corp, Duluth, Ga) in patients with subfoveal choroidal neovascularization (CNV) caused by age-related macular degeneration (AMD).
Details
Title
Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials - TAP report 2
Author(s)
Bressler, N. M.
Published in
Archives of ophthalmology
Volume
119
Issue
2
Pages
198-207
Date
2001
Publisher
American Medical Association
ISSN
0003-9950
Keywords
Record Appears in
Scientific production and competences > ENAC - School of Architecture, Civil and Environmental Engineering > ENAC Archives > LPAS - Air and Soil Pollution Laboratory
Scientific production and competences > STI - School of Engineering > STI Archives > GR-VDB - Van den Bergh Group
Scientific production and competences > SB - School of Basic Sciences > SB Archives > GR-VDB - Van den Bergh Group
Peer-reviewed publications
Work produced at EPFL
Journal Articles
Published
Scientific production and competences > STI - School of Engineering > STI Archives > GR-VDB - Van den Bergh Group
Scientific production and competences > SB - School of Basic Sciences > SB Archives > GR-VDB - Van den Bergh Group
Peer-reviewed publications
Work produced at EPFL
Journal Articles
Published
Record creation date
2011-02-16